BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8878582)

  • 1. Combination of PS-15, epiroprim, or pyrimethamine with dapsone in prophylaxis of Toxoplasma gondii and Pneumocystis carinii dual infection in a rat model.
    Brun-Pascaud M; Chau F; Garry L; Jacobus D; Derouin F; Girard PM
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2067-70. PubMed ID: 8878582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental evaluation of combined prophylaxis against murine pneumocystosis and toxoplasmosis.
    Brun-Pascaud M; Chau F; Simonpoli AM; Girard PM; Derouin F; Pocidalo JJ
    J Infect Dis; 1994 Sep; 170(3):653-8. PubMed ID: 8077724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study on the efficacy of epiroprim against developmental stages of Toxoplasma gondii and Pneumocystis carinii in animal models.
    Mehlhorn H; Dankert W; Hartman PG; Then RL
    Parasitol Res; 1995; 81(4):296-301. PubMed ID: 7624286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of epiroprim (Ro11-8958), a new dihydrofolate reductase inhibitor, in the treatment of acute Toxoplasma infection in mice.
    Martinez A; Allegra CJ; Kovacs JA
    Am J Trop Med Hyg; 1996 Mar; 54(3):249-52. PubMed ID: 8600759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model.
    Brun-Pascaud M; Chau F; Derouin F; Girard PM
    J Antimicrob Chemother; 1998 Mar; 41 Suppl B():57-62. PubMed ID: 9579714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of epiroprim (Ro 11-8958), a dihydrofolate reductase inhibitor, alone and in combination with dapsone against Toxoplasma gondii.
    Chang HR; Arsenijevic D; Comte R; Polak A; Then RL; Pechère JC
    Antimicrob Agents Chemother; 1994 Aug; 38(8):1803-7. PubMed ID: 7986011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of activity of artemether for prophylaxis and treatment of Toxoplasma gondii and Pneumocystis carinii infections in rat.
    Brun-Pascaud M; Chau F; Derouin F; Girard PM
    Parasite; 1996 Jun; 3(2):187-9. PubMed ID: 8758556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of folic acid synthesis in the treatment of experimental Pneumocystis carinii pneumonia.
    Walzer PD; Kim CK; Foy JM; Linke MJ; Cushion MT
    Antimicrob Agents Chemother; 1988 Jan; 32(1):96-103. PubMed ID: 3258144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug evaluation of concurrent Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium complex infections in a rat model.
    Brun-Pascaud M; Rajagopalan-Levasseur P; Chau F; Bertrand G; Garry L; Derouin F; Girard PM
    Antimicrob Agents Chemother; 1998 May; 42(5):1068-72. PubMed ID: 9593128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antiparasitic and antitumor activity of 2, 4-diamino-6-(arylmethyl)-5,6,7,8-tetrahydroquinazoline analogues of piritrexim.
    Rosowsky A; Papoulis AT; Forsch RA; Queener SF
    J Med Chem; 1999 Mar; 42(6):1007-17. PubMed ID: 10090784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations.
    Piper JR; Johnson CA; Krauth CA; Carter RL; Hosmer CA; Queener SF; Borotz SE; Pfefferkorn ER
    J Med Chem; 1996 Mar; 39(6):1271-80. PubMed ID: 8632434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
    Girard PM; Landman R; Gaudebout C; Olivares R; Saimot AG; Jelazko P; Gaudebout C; Certain A; Boué F; Bouvet E
    N Engl J Med; 1993 May; 328(21):1514-20. PubMed ID: 8479488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Pneumocystis carinii activity of PS-15, a new biguanide folate antagonist.
    Hughes WT; Jacobus DP; Canfield C; Killmar J
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1417-9. PubMed ID: 8363369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
    Bucher HC; Griffith L; Guyatt GH; Opravil M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun; 15(2):104-14. PubMed ID: 9241108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.
    Podzamczer D; Salazar A; Jiménez J; Consiglio E; Santín M; Casanova A; Rufí G; Gudiol F
    Ann Intern Med; 1995 May; 122(10):755-61. PubMed ID: 7717598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial activities of dihydrofolate reductase inhibitors, used singly or in combination with dapsone, against Mycobacterium ulcerans.
    Dhople AM
    J Antimicrob Chemother; 2001 Jan; 47(1):93-6. PubMed ID: 11152437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of dihydrofolate reductases from Toxoplasma gondii, Pneumocystis carinii, and rat liver by rotationally restricted analogues of pyrimethamine and metoprine.
    Rosowsky A; Queener SF; Cody V
    Drug Des Discov; 1999 Jul; 16(1):25-40. PubMed ID: 10466054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,4-Diamino-6,7-dihydro-5H-cyclopenta[d]pyrimidine analogues of trimethoprim as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase.
    Rosowsky A; Papoulis AT; Queener SF
    J Med Chem; 1998 Mar; 41(6):913-8. PubMed ID: 9526565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic combinations of Ro 11-8958 and other dihydrofolate reductase inhibitors with sulfamethoxazole and dapsone for therapy of experimental pneumocystosis.
    Walzer PD; Foy J; Steele P; White M
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1436-43. PubMed ID: 8363372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine.
    Mallolas J; Zamora L; Gatell JM; Miró JM; Vernet E; Valls ME; Soriano E; SanMiguel JG
    AIDS; 1993 Jan; 7(1):59-64. PubMed ID: 8442918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.